SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $263,000 | -15.7% | 69,351 | 0.0% | 0.00% | – |
Q4 2021 | $312,000 | -3.4% | 69,351 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $323,000 | -33.8% | 69,351 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $488,000 | +19.3% | 69,351 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $409,000 | +13.9% | 69,351 | -11.2% | 0.00% | 0.0% |
Q4 2020 | $359,000 | – | 78,089 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |